Skip to content

Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula

A Pilot Study to Assess the Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening (Curaseal AF) as a Treatment for Perianal Fistula

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03381365
Enrollment
6
Registered
2017-12-22
Start date
2016-09-01
Completion date
2018-12-31
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fistula in Ano

Brief summary

The investigators aim to assess the efficacy of the Curaseal anal plug in patients with idiopathic uncomplicated fistulous tracts. Healing of the fistula tract will be assessed both clinically and radiologically with MR imaging.

Detailed description

Perianal fistula is a challenging condition for colorectal surgeons. Achieving a favourable balance between healing and incontinence is the key to success. Surgeons have adopted many methods to close off this abnormal tract, which include laying opening, use of setons, advancement flaps and permanent stoma. A more recent approach has been the use of devices or substances to block the tract in the hope that it will seal off. Most of the devices that have been used to close the tract have not proved to be as effective in healing as a lay open with high rates of fistula persistence. A major failure of the devices has been their early expulsion and their inability to seal off the internal opening. The new Curaseal plug may be able to overcome these shortcomings. This plug has a disc to seal the internal opening, with a suture to be placed at the external opening, which may prevent it falling out and ensure internal opening closure. The investigators aim to assess the efficacy of the Curaseal anal plug in patients with idiopathic uncomplicated fistulous tracts. Healing of the fistula tract will be assessed both clinically and radiologically with MR imaging.

Interventions

DEVICECuraSeal Percutaneous Intraluminal Closure System

Sponsors

London North West Healthcare NHS Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are psychologically stable and suitable for intervention and able to provide informed consent * Patients who are willing and competent to fill in questionnaires and undergo investigations at various time points during the study * Patients with an idiopathic extra and trans-sphincteric perianal fistula.

Exclusion criteria

* Patients aged less than 18 or \>80 years. * Patients unfit to undergo general or spinal anaesthesia. * Patients with a supra-levator fistula. * Patients with a rectovaginal fistula. * Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis). * Patients with a fistula secondary to trauma, foreign body, developmental cyst or pelvic irradiation. * Patients who are immunosuppressed.

Design outcomes

Primary

MeasureTime frameDescription
fistula healing1 yearclinical and radiological healing

Secondary

MeasureTime frame
adverse effects or perioperative compilations related to devicewithin first year

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026